Institut Mérieux; diagnostics, immunotherapy, food safety; nutrition; infectious diseases; cancers
Institut Mérieux lends its experience in industrial biology to the service of medicine and public health across the globe. In order to combat infectious diseases and cancers, it develops additional solutions in the fields of diagnostics, immunotherapy, food safety and nutrition.
Through its three bio-industrial companies, bioMérieux, Transgene and Mérieux NutriSciences, and working closely with its innovation-focused entities (Mérieux Développement and ABL Inc.), Institut Mérieux offers new solutions to worldwide public health challenges. It has established long-standing relationship with China. With its companies and Fondation Mérieux, Institut Mérieux has fostered an approach based on partnerships with the Chinese healthcare authorities and stakeholders in order to address major health issues in China: healthcare-associated infections, bacterial resistance, respiratory diseases, tuberculosis, cancerology and food safety…
